Decreased serum BDNF levels, along with a continuum of MCI to AD, indicate a reduced BDNF systemic availability that plays a role in the neurodegenerative process. The presence of the Met-BDNF allele and the APOE ε4 gene predict a worsened cognitive outcome in MCI patients. Here, APOE is linked to Alzheimer disease.